Schwarzbein Principle Programs, Inc. – Trademark Portfolio
Entity Type: 03
Schwarzbein Principle Programs, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HEALTH IS A CHOICE. The owner is based in Santa Barbara, CA.
Suite A102
Santa Barbara, CA 93105
Showing of trademarks Trademarks
Trademark Classifications
Schwarzbein Principle Programs, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Schwarzbein Principle Programs, Inc. have?
Schwarzbein Principle Programs, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Schwarzbein Principle Programs, Inc. file in?
Schwarzbein Principle Programs, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Schwarzbein Principle Programs, Inc.'s most well-known trademarks?
Schwarzbein Principle Programs, Inc.'s registered trademark portfolio includes well-known marks such as HEALTH IS A CHOICE. These are among 1 currently registered trademark in the portfolio.
What is Schwarzbein Principle Programs, Inc.'s trademark registration success rate?
Schwarzbein Principle Programs, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.